NCT05814809View on ClinicalTrials.gov

Clinical Trial to Evaluate the Safety and Pharmacokinetics of JP-1366 in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2022

Primary Completion Date

October 9, 2022

Study Completion Date

November 9, 2022

Conditions
Healthy
Interventions
DRUG

JP-1366 20mg tablet

T : JP-1366 20mg tablet

DRUG

JP-1366 20mg capsule

R : JP-1366 20mg capsule

Trial Locations (1)

Unknown

Yangji Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Onconic Therapeutics Inc.

INDUSTRY

NCT05814809 - Clinical Trial to Evaluate the Safety and Pharmacokinetics of JP-1366 in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter